Explore the alinity family Alinityci-series INTEGRATED CLINICAL CHEMISTRY & IMMUNOASSAY SYSTEM Streamlined system offers powerful integration across clinical chemistry and immunoassay. Can easily scale, combining up to four modules in multiple configurations to meet your laboratory's needs and maximize its ...
GLP systems Track is innovative lab automation that offers proven technology with greater flexibility and scalability options.
As the global leader in diagnostic point-of-care testing, Abbott has more than 120 scientists who are researching and developing Abbott's concussion assessment test for the next generation i-STAT Alinity system. The i-STAT system, which is already in use within the military as well as in hos...
The blood test is being developed for Abbott's next generation handheld blood analyzer: i-STAT™ Alinity™ system. The concussion assessment test in development would detect two biomarkers associated with brain injury: *GFAP and *UCH-L1. Those biomarkers may be released into the bloodstream ...
Our Alinity family of diagnostic instruments, which was engineered to be faster and simpler to operate within a smaller footprint, continues to rollout. As Alinity penetrates new markets and wins renewals with established customers, the benefits for Abbott's performance will continue to grow. Heart...
Dec 14, 2023 Abbott’s New Lab Automation System, GLP Systems Track, Receives FDA Approval, Providing Labs and Patients with Faster Results Nov 13, 2023 Late-Breaking Data Show an Aspirin-Free Medication Regimen Benefits People with Abbott's HeartMate 3™ Heart Pump Nov 8, 2023 Participants ...
During the third quarter, Abbott received U.S. FDA approval for its Alinity®-S diagnostics system, the latest technology for screening and protecting the U.S. blood and plasma supply. “We’re performing exceptionally well across several areas,” saidMiles D. White, chairman and chief execut...
Abbott sales increased 5.5 percent to $8.08 billion in the third quarter. Its three key growth platforms include the FreeStyle Libre continuous glucose monitor, Alinity diagnostics system and MitraClip device for leaky heart valves. gfxsubhead ...
and blood screening. While our Alinity family of diagnostic systems first launched more than six years ago, given the long contract cycles common in the diagnostics industry, we continue to see a benefit in our contract renewal and competitive win rates, with several recent large account wins exp...
that’s working well. I have said the Alinity it’s a multiyear kind of cycle. If you look at these contracts they are 7 years to 10 years. So, every year you got 15% that’s coming up for renewal. I have also said we are trying to strike the balance between top line growth an...